Measurement of Soluble Interleukin 2 Receptor in Sera of Adult Patients with Hematological or Solid Malignancies

References

• Robb R. J., Munck A., Smith K. A. T cell growth factor receptors: quantitation, specificity and biological relevance. J. Exp. Med 1981; 154: 1455–1474
   PubMed Web of Science ®Google Scholar
• Tsudo M., Vchiyama T., Vchino H. Expression of Tac antigen on activated normal human B-cells. J. Exp. Med 1984; 160: 612–617
   PubMed Web of Science ®Google Scholar
• Uchizama T., Brader S., Waldmann T. A. A monoclonal antibody (anti Tac) reactive with activated and functionally mature human T cell. 1 Production of anti-Tac monoclonal antibody and distribution of Tac(+) cells. J. Immunol 1981; 126: 1393–1403
   PubMedGoogle Scholar
• Tsudo M., Kozak R. W., Goldman C. K., Waldmann T. A. Demonstration of a non-Tac peptide that binds interleukin 2: A potential participant in a multichain interleukin 2 receptor complex. Proc. Natl. Acad. Sci. USA 1986; 83: 9694–9698
   PubMed Web of Science ®Google Scholar
• Robb R. J., Greene W. C., Rusk C. M. Internalization of receptor for interleukin 2. Implications for the level of Tac antigen. J. Exp. Med 1984; 160: 1126–1146
   PubMed Web of Science ®Google Scholar
• Tsudo M., Kozak R. W., Goldman C. K., Waldmann T. A. Contribution of a p75 interleukin 2 binding peptide to a high-affinity interleukin 2 receptor complex. Proc. Natl. Acad. Sci. USA 1987; 84: 4215–4218
   PubMed Web of Science ®Google Scholar
• Teshigawara K., Wang H. M., Kato K., Smith K. A. Interleukin 2 high affinity receptor expression requires two distinct binding proteins. J. Exp. Med 1987; 165: 223–238
   PubMed Web of Science ®Google Scholar
• Cantrell D. A., Smith K. A. Transcient expression of interleukin 2 receptors. Consequence of T cell growth. J. Exp. Med 1983; 158: 1895–1911
   PubMed Web of Science ®Google Scholar
• Waldmann T. A., Goldman C. K., Robb R. J., Depper J. M., Leonard W. J., Sharrow S. O., Bongiovanni K. F., Korsmeyer S. J., Green W. C. Expression of interleukine 2 receptor on activated human B cells. J. Exp. Med 1984; 160: 1450–1466
   PubMed Web of Science ®Google Scholar
• Korsmeyer S. J., Green W. P., Cossman J., Hsu S. M., Jensen J. P., Neckers L. M., Marshall S. L., Bakhshi A., Depper J. M., Leonard W. J., Joffe E. S., Waldmann T. A. Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia. Proc. Natl. Acad. Sci. USA 1983; 80: 4522–4526
   PubMed Web of Science ®Google Scholar
• Depper J. M., Leonard W. J., Kr<154>nke M., Waldmann T. A., Greene W. C. Augmented T-cell growth factor receptor expression in HTLV-1 infected human leukemic T-cell. J. Immunol 1984; 133: 1691–1695
   PubMed Web of Science ®Google Scholar
• Rubin L. A., Kurman C. C., Fritz M. E., Biddison W. E., Bautin B., Yarchoan R., Nelson D. L. Soluble interleukine 2 receptor are released from activated human lymphoid cells in vitro. J. Immunol 1985; 135: 3172–3177
   PubMed Web of Science ®Google Scholar
• Chilosi M., Pizzolo G., Semenzato G., Cetto G. Detection of soluble form of the receptor for interleukine 2 receptor in the serum of patients with hairy cell leukemia. Int. J. Biol. Markers 1986; 1: 101–104
   PubMedGoogle Scholar
• Pizzolo G., Chilosi M., Vinanti F., Dozzi F., Lestani M., Perona G., Perini A., Todeschini G., Vincenzi P., Trentin L., Semenzato G. Soluble interleukine-2 receptor in the serum of patients with Hodgkin's disease. Br. J. Cancer 1987; 55: 427–428
   PubMed Web of Science ®Google Scholar
• Semenzato G., Foa R., Agostini C., Zanbello R., Trentin L., Vinante F., Benedetti F., Chilosi M., Pizzolo G. High serum levels of soluble interleukine 2 receptor in patients with B chronic lymphocytic leukemia. Blood 1987; 70: 396–400
   PubMed Web of Science ®Google Scholar
• National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas. Summary and description of a working formulation for clinical usage. The non-Hodgkin's lymphoma pathologic classification project. Cancer 1982; 49: 2112–2135
   PubMed Web of Science ®Google Scholar
• Rai K. R., Sawitsky A., Cronkite E. P., Chanana A. D., Levy R. N., Pasternack B. S. Clinical staging of chronic lymphocytic leukemia. Blood 1975; 46: 219–234
   PubMed Web of Science ®Google Scholar
• Carbone P. P. Report of the committee on Hodgkin's disease staging classification. Cancer Res 1971; 31: 1860–1861
   PubMed Web of Science ®Google Scholar
• Kay N. E., Burton J., Wagner D., Nelson D. L. The malignant B cells from B-chronic lymphocytic leukemia patients release TAC-soluble interleukin-2 receptors. Blood 1988; 72: 447–450
   PubMed Web of Science ®Google Scholar
• Semenzato G., Trentin L., Zambello R., Agostini C., Bulian P., Siviero F., Ambrosetti A., Vinante F., Prior M., Chilosi M., Pizzolo G. Origin of the soluble interleukin-2 receptor in the serum of patients with hairy cell leukemia. Leukemia 1988; 2: 788–792
   PubMed Web of Science ®Google Scholar
• Nelson D. L., Rubin L. A., Kurman C. C., Fritz M. E., Boutin B. Analysis of the cellular requirements for the production of soluble interleukin 2 receptor in vitro. J. Clin. Immunology 1986; 6: 114–120
   PubMed Web of Science ®Google Scholar
• LeBien T. W., McCormack R. T. The common acute lymphoblastic leukemia antigen (CD10)—Emancipation from a functional enigma. Blood 1989; 73: 625–635
   PubMed Web of Science ®Google Scholar
• Pui C. H., Ip S. H., Kung P., Dodge R. K., Berard C. W., Crist W. M., Murphy S. B. High serum interleukin-2 receptor levels are related to advanced disease and poor outcome in childhood non-Hodgkin's lymphoma. Blood 1987; 70: 624–628
   PubMed Web of Science ®Google Scholar
• Pui C. H., Ip S. H., Iflah S., Behm F. G., Grose B. H., Dodge R. K., Crist W. M., Forman W. L., Murphy S. B., Riviera G. K. Serum interleukin-2 receptor levels in childhood acute lymphoblastic leukemia. Blood 1988; 71: 1135–1137
   PubMed Web of Science ®Google Scholar
• Chilosi M., Semenzato G., Cetto G., Ambrosetti A., Fiore-Donati L., Perona G., Berton G., Lestani M., Scarpa A., Agostini C., Trentin L., Zambello R., Masciarelli M., Dazzi F., Vinante F., Caligaris-Cappio F., Pizzolo G. Soluble interleukin-2 receptors in the sera of patients with hairy cell leukemia: relationship with the effect of recombinant alpha-interferon therapy on clinical parameters and natural killer in vitro activity. Blood 1987; 70: 1530–1535
   PubMed Web of Science ®Google Scholar
• Kupiec-Weglinski J. W., Diamantstein T., Tilney N. L. Interleukin 2 receptor-targeted therapy-rationale and application in organ transplantation. Transplantation 1988; 46: 785–792
   PubMed Web of Science ®Google Scholar
• Roodman S. T., Miller L. W., Tsai C. C. Role of interleukin 2 receptors in immunologic monitoring following cardiac transplantation. Transplantation 1988; 45: 1050–1056
   PubMed Web of Science ®Google Scholar